The value of value assessments

We’ve reached a point where research about patient access to medicines and research into value assessments have become inextricably intertwined. Any look at how to improve access for patients must include a peek at how health technology assessments and other potentially suitable tools are used. It’s an incredibly important topic, which is why I was so happy to see Kimberly Westrich and her team publish their latest piece in the Journal of Managed Care & Specialty Pharmacy examining how health payers perceive and make use of value assessment tools.

It's evident from this study that payers view value frameworks as useful, pointing out ICER’s growing footprint and influence within the U.S. health care payer community. The results are also a reminder of why it is so important that we evaluate what value assessments often don’t capture, such as the indirect benefits of a new technology or medicine on a patient’s quality of life or productivity. NPC proudly continues to lead the discussion on these important questions.

Thanks to Kimberly and the rest of her team for this insightful paper on this crucial topic.?